C07D 207/416
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
C07D207/416 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 363 US grants and 339 published applications in this corpus.
Search patents in C07D- Granted patents
- 363
- Published applications
- 339
- Assignees
- 234
- Inventors
- 1,038
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 8 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 5 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 7 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 11 | 0 |
| 2000 | 7 | 0 |
| 2001 | 10 | 3 |
| 2002 | 16 | 17 |
| 2003 | 15 | 14 |
| 2004 | 12 | 19 |
| 2005 | 11 | 19 |
| 2006 | 8 | 13 |
| 2007 | 16 | 20 |
| 2008 | 10 | 16 |
| 2009 | 7 | 17 |
| 2010 | 10 | 13 |
| 2011 | 13 | 15 |
| 2012 | 6 | 12 |
| 2013 | 11 | 19 |
| 2014 | 14 | 13 |
| 2015 | 15 | 11 |
| 2016 | 12 | 14 |
| 2017 | 10 | 5 |
| 2018 | 4 | 13 |
| 2019 | 11 | 10 |
| 2020 | 11 | 16 |
| 2021 | 11 | 12 |
| 2022 | 10 | 13 |
| 2023 | 12 | 15 |
| 2024 | 4 | 8 |
| 2025 | 6 | 8 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Linker, antibody-drug conjugate including same and use thereof30 Jun 2026US 12,668,573 B2Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd
- Method for producing derivative of organic substance and method for analyzing sample containing organic substance7 Apr 2026US 12,595,229 B2Ajinomoto Co., Inc.
- Small molecules against cereblon to enhance effector T cell function3 Mar 2026US 12,564,583 B2Lee Moffitt Cancer Center and Research Institute, Inc.
- Antimicrobial compounds and nanostructures27 Jan 2026US 12,534,433 B2The Boeing Company
- PSMA binding ligand-linker conjugates and methods for using16 Dec 2025US 12,496,292 B2Purdue Research Foundation
- Amine hydrochloride having maleimide group, and method for producing same6 Aug 2026US 2026/0226004 A1Nof Corporation
- Method for producing derivative of organic substance and method for analyzing sample containing organic substance16 Jul 2026US 2026/0200843 A1Ajinomoto Co., Inc.
- Wnt signaling pathway inhibitors for treatments of disease21 May 2026US 2026/0138966 A1University of Maryland, Baltimore
- Novel ionizable lipids and lipid nanoparticles and methods of using the same5 Mar 2026US 2026/0060926 A1Sail Biomedicines
- Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders18 Dec 2025US 2025/0382265 A1Uniwersytet Jagiellonski
Most cited
By later US patents
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000
- Reversible pegylated drugs106US 7,585,837 B2Yeda Research and Development Co. Ltd. · 2009
- Crosstalk inhibitors and their uses103US 5,525,524 ABiosite Diagnostics, Inc. · 1996
- Aryl substituted pyrazoles, and pyrroles, and the use thereof95US 6,414,011 B1Euro-Celtique S. A. · 2002
- Compositions and methods of the use thereof achiral analogues of CC-1065 and the duocarmycins81US 6,660,742 B2Taiho Pharmaceutical Co., Ltd. · 2003